Mon, November 13, 2023

David Westenberg Maintained (AKYA) at Buy with Decreased Target to $8 on, Nov 13th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-8-on-nov-13th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $11 to $8 on, Nov 13th, 2023.

David has made no other calls on AKYA in the last 4 months.



There are 2 other peers that have a rating on AKYA. Out of the 2 peers that are also analyzing AKYA, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $8 on, Tuesday, October 24th, 2023
  • John Sourbeer of "UBS" Maintained at Strong Buy with Decreased Target to $7 on, Thursday, October 12th, 2023